Meta-Regression of Adjunctive Treatment Trials for Negative and Other Residual Symptoms in Schizophrenia: A Differential Relationship of Treatment and Placebo Response With Sample Size

被引：0
|
作者：
Kantrowitz, Joshua [1 ]
Mayer, Megan [1 ]
Choo, Tse Hwei [1 ]
Liu, Kevin [1 ]
Govani, Viraj [1 ]
Francis, Shyanne [1 ]
Javitt, Daniel [1 ]
机构：
[1] Columbia Univ, New York, NY USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2023年 / 48卷
关键词：
CNS Clinical Trials; Clinical Development; Negative Symptoms;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P491
引用
收藏
页码：349 / 349
页数：1
相关论文
共 45 条
  • [31] IS THE INCIDENCE RATE OF ASCVD EVENTS IN THE PLACEBO ARM OF RANDOMIZED TRIALS ASSOCIATED WITH THE TREATMENT EFFECT OF ASPIRIN FOR PRIMARY PREVENTION? A META-REGRESSION ANALYSIS
    Nudy, Matthew
    Cooper, Jennifer
    Ghahramani, Mehrdad
    Mandrola, John
    Foy, Andrew
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1881 - 1881
  • [32] Placebo Response in Repetitive Transcranial Magnetic Stimulation Trials of Treatment of Auditory Hallucinations in Schizophrenia: A Meta-Analysis
    Dollfus, Sonia
    Lecardeur, Laurent
    Morello, Remy
    Etard, Olivier
    SCHIZOPHRENIA BULLETIN, 2016, 42 (02) : 301 - 308
  • [33] Relationship between quality of reports of antidepressant randomized controlled trials and treatment estimates - Systematic review, meta-analysis, and meta-regression analysis
    Cipriani, Andrea
    Malvini, Lara
    Furukawa, Toshiaki A.
    Barbui, Corrado
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (04) : 352 - 356
  • [34] Influence of treatment length on nocebo response, drug response and drug safety in ADHD: A meta-regression analysis of 105 randomized controlled trials
    Saco, David Ramirez
    Na, Maghie Barcheni
    Albaladejo, Magi Farre
    Clotet, Ruth Cunill
    Cervello, Xavier Castells
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2022, 130 : 43 - 44
  • [35] RETRACTED: Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind, randomized, placebo-controlled trial (Retracted Article)
    Abdallah, Mahmoud S.
    Mosalam, Esraa M.
    Hassan, Ahmed
    Ramadan, Ahmed N.
    Omara-Reda, Hend
    Zidan, Abdel-Aziz A.
    Samman, Waad A.
    El-Berri, Eman, I
    CNS NEUROSCIENCE & THERAPEUTICS, 2023, 29 (01) : 354 - 364
  • [36] Efficacy of Second-Generation-Antipsychotics in the treatment of negative symptoms of schizophrenia: A meta-analysis of randomized clinical trials
    Darba, Josep
    Minoves, Agnes
    Rojo, Emilio
    Jimenez, Francesca
    Rejas, Javier
    REVISTA DE PSIQUIATRIA Y SALUD MENTAL, 2011, 4 (03): : 126 - 143
  • [37] The association between sample and treatment characteristics and the efficacy of repetitive transcranial magnetic stimulation in depression: A meta-analysis and meta-regression of sham-controlled trials
    Dalhuisen, Iris
    van Bronswijk, Suzanne
    Bors, Jeanine
    Smit, Filip
    Spijker, Jan
    Tendolkar, Indira
    Ruhe, Henricus G.
    van Eijndhoven, Philip
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2022, 141
  • [38] A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Pimavanserin as an Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE-2) in Patients With Predominant Negative Symptoms
    Bugarski-Kirola, Dragana
    Liu, I-Yuan
    Arango, Celso
    Marder, Stephen R.
    SCHIZOPHRENIA BULLETIN, 2025,
  • [39] THE DOSE RESPONSE RELATIONSHIP OF CARISBAMATE AS AN ADJUNCTIVE TREATMENT FOR PARTIAL ONSET SEIZURES BASED ON PHARMACOKINETIC/PHARMACODYNAMIC MODELING OF 3 RANDOMIZED, PLACEBO-CONTROLLED TRIALS
    Faught, E.
    Sperling, M.
    De Ridder, F.
    Schmitt, J.
    Kimko, H.
    Novak, G.
    EPILEPSIA, 2009, 50 : 51 - 51
  • [40] THE GUT-MICROBIOTA AS A TARGET FOR THE TREATMENT OF NEGATIVE SYMPTOMS OF SCHIZOPHRENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF CONTROLLED TRIALS OF ADD-ON STRATEGIES
    Minichino, Amedeo
    Brondino, Natascia
    Solmi, Marco
    Del Giovane, Cinzia
    Correll, Christoph U.
    Fusar-Poli, Paolo
    Burnet, Philip
    Cipriani, Andrea
    Lennox, Belinda
    SCHIZOPHRENIA BULLETIN, 2020, 46 : S298 - S298
12345